Literature DB >> 30320525

Recommendations for the Appropriate Structure, Communication, and Investigation of Tobacco Harm Reduction Claims. An Official American Thoracic Society Policy Statement.

Frank T Leone, Kai-Håkon Carlsen, David Chooljian, Laura E Crotty Alexander, Frank C Detterbeck, Michelle N Eakin, Sarah Evers-Casey, Harold J Farber, Patricia Folan, Hasmeena Kathuria, Karen Latzka, Shane McDermott, Sharon McGrath-Morrow, Farzad Moazed, Alfred Munzer, Enid Neptune, Smita Pakhale, David P L Sachs, Jonathan Samet, Beth Sufian, Dona Upson.   

Abstract

RATIONALE: The tobacco harm reduction literature is replete with vague language, far-reaching claims, and unwarranted certainty. The American Thoracic Society has increasingly recognized the need for a framework for reliably making such claims. Evidence-based standards improving the scientific value and transparency of harm reduction claims are expected to improve their trustworthiness, clarity, and consistency.
METHODS: Experts from relevant American Thoracic Society committees identified key topic areas for discussion. Literature search strategy included English language articles across Medline, Google Scholar, and the Cochrane Collaborative databases, with expanded search terms including tobacco, addiction, smoking, cigarettes, nicotine, and harm reduction. Workgroup members synthesized their evidentiary summaries into a list of candidate topics suitable for inclusion in the final report. Breakout groups developed detailed content maps of each topic area, including points to be considered for suggested recommendations. Successive draft recommendations were modified using an iterative consensus process until unanimous approval was achieved. Patient representatives ensured the document's relevance to the lay public.
RESULTS: Fifteen recommendations were identified, organized into four framework elements dealing with: estimating harm reduction among individuals, making claims on the basis of population impact, appropriately careful use of language, and ethical considerations in harm reduction. DISCUSSION: This statement clarifies important principles guiding valid direct and inferential harm reduction claims. Ideals for effective communication with the lay public and attention to unique ethical concerns are also delineated. The authors call for formal systems of grading harm reduction evidence and regulatory assurances of longitudinal surveillance systems to document the impact of harm reduction policies.

Entities:  

Keywords:  addiction; e-cigarettes; prevention; smoking; tobacco dependence

Mesh:

Year:  2018        PMID: 30320525      PMCID: PMC6943880          DOI: 10.1164/rccm.201808-1443ST

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  82 in total

Review 1.  Do smoking reduction interventions promote cessation in smokers not ready to quit?

Authors:  Taghrid Asfar; Jon O Ebbert; Robert C Klesges; George E Relyea
Journal:  Addict Behav       Date:  2011-02-12       Impact factor: 3.913

2.  Smokers' beliefs about the relative safety of other tobacco products: findings from the ITC collaboration.

Authors:  Richard J O'Connor; Ann McNeill; Ron Borland; David Hammond; Bill King; Christian Boudreau; K Michael Cummings
Journal:  Nicotine Tob Res       Date:  2007-10       Impact factor: 4.244

3.  Grading quality of evidence and strength of recommendations for diagnostic tests and strategies.

Authors:  Holger J Schünemann; A Holger J Schünemann; Andrew D Oxman; Jan Brozek; Paul Glasziou; Roman Jaeschke; Gunn E Vist; John W Williams; Regina Kunz; Jonathan Craig; Victor M Montori; Patrick Bossuyt; Gordon H Guyatt
Journal:  BMJ       Date:  2008-05-17

4.  Building healthy public policy: don't believe the misdirection.

Authors:  Michael Sparks
Journal:  Health Promot Int       Date:  2011-09       Impact factor: 2.483

Review 5.  Passive smoking and sudden infant death syndrome: review of the epidemiological evidence.

Authors:  H R Anderson; D G Cook
Journal:  Thorax       Date:  1997-11       Impact factor: 9.139

6.  Prenatal nicotine exposure alters lung function and airway geometry through α7 nicotinic receptors.

Authors:  Cherry Wongtrakool; Ningshan Wang; Dallas M Hyde; Jesse Roman; Eliot R Spindel
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01-12       Impact factor: 6.914

Review 7.  Effect of smokeless tobacco (snus) on smoking and public health in Sweden.

Authors:  J Foulds; L Ramstrom; M Burke; K Fagerström
Journal:  Tob Control       Date:  2003-12       Impact factor: 7.552

8.  Lung function trajectories from birth through puberty reflect asthma phenotypes with allergic comorbidity.

Authors:  Karin C Lødrup Carlsen; Petter Mowinckel; Vegard Hovland; Geir Håland; Amund Riiser; Kai-Håkon Carlsen
Journal:  J Allergy Clin Immunol       Date:  2014-07-03       Impact factor: 10.793

9.  Age of smoking initiation: implications for quitting.

Authors:  J Chen; W J Millar
Journal:  Health Rep       Date:  1998       Impact factor: 4.796

10.  Filter presence and tipping paper color influence consumer perceptions of cigarettes.

Authors:  Richard J O'Connor; Maansi Bansal-Travers; K Michael Cummings; David Hammond; James F Thrasher; Cindy Tworek
Journal:  BMC Public Health       Date:  2015-12-22       Impact factor: 3.295

View more
  5 in total

1.  Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline.

Authors:  Frank T Leone; Yuqing Zhang; Sarah Evers-Casey; A Eden Evins; Michelle N Eakin; Joelle Fathi; Kathleen Fennig; Patricia Folan; Panagis Galiatsatos; Hyma Gogineni; Stephen Kantrow; Hasmeena Kathuria; Thomas Lamphere; Enid Neptune; Manuel C Pacheco; Smita Pakhale; David Prezant; David P L Sachs; Benjamin Toll; Dona Upson; Dan Xiao; Luciane Cruz-Lopes; Izabela Fulone; Rachael L Murray; Kelly K O'Brien; Sureka Pavalagantharajah; Stephanie Ross; Yuan Zhang; Meng Zhu; Harold J Farber
Journal:  Am J Respir Crit Care Med       Date:  2020-07-15       Impact factor: 21.405

2.  Assessing the lung cancer risk reduction potential of candidate modified risk tobacco products.

Authors:  Julia Hoeng; Serge Maeder; Patrick Vanscheeuwijck; Manuel C Peitsch
Journal:  Intern Emerg Med       Date:  2019-02-14       Impact factor: 3.397

Review 3.  What are the respiratory effects of e-cigarettes?

Authors:  Jeffrey E Gotts; Sven-Eric Jordt; Rob McConnell; Robert Tarran
Journal:  BMJ       Date:  2019-09-30

4.  Prevalence and burden of obstructive lung disease in the urban poor population of Ottawa, Canada: a community-based mixed-method, observational study.

Authors:  Smita Pakhale; Saania Tariq; Nina Huynh; Sadia Jama; Tina Kaur; Catherine Charron; Kelly Florence; Fozia Nur; Margaret Ella Bustamante-Bawagan; Ted Bignell; Robert Boyd; Joanne Haddad; Tetyana Kendzerska; Gonzalo Alvarez
Journal:  BMC Public Health       Date:  2021-01-21       Impact factor: 3.295

5.  Turkish Thoracic Society's Statement Report on Electronic Cigarettes and Heated Tobacco Products.

Authors:  Pelin Duru Çetinkaya; Pınar Pazarlı Bostan; Banu Salepçi; Aslı Görek Dilektaşlı; Osman Elbek; Filiz Çağla Uyanusta Küçük; Dilek Karadoğan; Seren Arpaz; Seyhan Dülger; Mehmet Atilla Uysal; Esra Uzaslan; Cengiz Özge; Oğuz Kılınç; Elif Dağlı; Oya Itil
Journal:  Turk Thorac J       Date:  2022-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.